 |
인쇄하기
취소
|
Dong-A to launch biosimilar plant in Songdo
Published: 2011-10-04 06:57:00
Updated: 2011-10-04 06:57:00
Dong-A Pharmaceutical Co., the nation’s No.1 drug maker, said Thursday that it signed a memorandum of understanding (MOU) with Incheon Free Economic Zone (IFEZ) Authority to build and operate a a global biomedicine complex including a biosimilar plant in Songdo, some 30 kilometers west of Seoul near Incheon International Airport.
Designated as Korea’s first FEZ in 2003, the Incheon FEZ is si...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.